Drugmaker caps insulin costs at $35 to help diabetes patients during pandemic

Drugmaker caps insulin costs at $35 to help diabetes patients during pandemic
Pharmaceutical manufacturer Eli Lilly said Tuesday that it will limit the out-of-pocket cost of insulin to $35 per month to offset financial hardships due to the coronavirus pandemic.The co-pay cap will cover the majority of the company’s Insulin,...

Source: https://ift.tt/3e3vKj4